Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.22.2.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 6 Months Ended
Jun. 30, 2022
Accounting Policies [Abstract]  
SCHEDULE OF OTHER CURRENT ASSETS

Other current assets consisted of the following as of June 30, 2022 and December 31, 2021:

 

    June 30, 2022     December 31, 2021  
    (unaudited)        
Lab supply inventory   $ 2,007     $ 1,786  
Prepaid expenses     582       800  
Other     108       108  
Total other current assets   $ 2,697     $ 2,694  
SCHEDULE OF BASIC AND DILUTED NET LOSS PER SHARE

 

    2022     2021     2022     2021  
    Three Months     Six Months Ended  
    Ended June 30,     June 30,  
    2022     2021     2022     2021  
    (unaudited)     (unaudited)  
Basic weighted average number of common shares         4,229              4,102             4,219              4,095    
Potential dilutive effect of stock-based awards     -       -       -       -  
Diluted weighted average number of common shares     4,229          4,102             4,219              4,095    
SCHEDULE OF ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE

 

    Three Months     Six Months Ended  
    Ended June 30,     June 30,  
    2022     2021     2022     2021  
    (unaudited)     (unaudited)  
Options     641       747       641       747  
Restricted stock units (RSUs)     351       373       351       373  
Warrants     63       1,405       63       1,405  
      1,055       2,525       1,055       2,525